 Aged
"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
| Descriptor ID |
D000368
|
| MeSH Number(s) |
M01.060.116.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 99 | 99 | | 1997 | 0 | 126 | 126 | | 1998 | 1 | 120 | 121 | | 1999 | 0 | 122 | 122 | | 2000 | 3 | 166 | 169 | | 2001 | 1 | 170 | 171 | | 2002 | 0 | 198 | 198 | | 2003 | 1 | 264 | 265 | | 2004 | 3 | 292 | 295 | | 2005 | 1 | 355 | 356 | | 2006 | 2 | 384 | 386 | | 2007 | 2 | 438 | 440 | | 2008 | 0 | 476 | 476 | | 2009 | 0 | 526 | 526 | | 2010 | 2 | 556 | 558 | | 2011 | 0 | 607 | 607 | | 2012 | 0 | 660 | 660 | | 2013 | 0 | 777 | 777 | | 2014 | 0 | 826 | 826 | | 2015 | 2 | 928 | 930 | | 2016 | 0 | 961 | 961 | | 2017 | 0 | 1036 | 1036 | | 2018 | 0 | 1118 | 1118 | | 2019 | 0 | 1167 | 1167 | | 2020 | 0 | 971 | 971 | | 2021 | 0 | 911 | 911 | | 2022 | 0 | 412 | 412 | | 2023 | 0 | 398 | 398 | | 2024 | 0 | 1176 | 1176 | | 2025 | 0 | 1290 | 1290 | | 2026 | 0 | 485 | 485 |
To return to the timeline, click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
Bock AM, Feng L, Chauhan A, Falchi L, Merryman R, Godbole S, Thiruvengadam SK, Jallouk AP, Major A, D'Angelo C, Ayers A, Baron K, Farahat OM, Shouse G, Danilov A, Bair S, Lunning M, Bhaskar S, Herrera AF, Sawalha Y, Flowers CR, Crombie JL, Salles G, Epperla N, Ahmed S. Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab. Blood Adv. 2026 Aug 25; 10(16):5496-5504.
-
Salive ME, Tjaden AH, Ames JR, Crandall JP, Dabelea D, Hazuda HP, Heckman-Stoddard BM, Huckfeldt PJ, Kuo S, Strotmeyer ES, Temprosa M, Venditti EM. Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes. JAMA. 2026 08 18; 336(7):577-586.
-
Flerlage JE, Eichenauer DA, Fuchs M, Hartmann S, Eich HT, Savage KJ, Lo AC, Skinnider B, Akhtar S, Rauf MS, Maghfoor I, Pinnix CC, Steiner R, Milgrom SA, Vega F, Alomari M, Zhang XY, Collins GP, Advani RH, Kumar P, Dickinson M, Wirth A, Tsang R, Prica A, Major A, Smith S, Hendrickson PG, Kelsey CR, Hopkins D, McKay P, Ng A, Koenig J, Constine LS, Casulo C, Sakthivel G, Baron J, Plastaras JP, Roberts KB, Gao S, Al Kendi J, Al Rahbi N, Balogh A, Levis M, Ricardi U, Sridhar A, Torka P, Specht L, De Silva R, Shah N, Pickard K, Osborne W, Blazin LJ, Henry M, Chang I, Smith CM, Halperin D, Miall F, Brady JL, Mikhaeel G, Brennan B, Penn A, Senchenko MA, Volchkov EV, Reeves M, Hoppe B, Terezakis S, Talaulikar D, Della Pepa R, Picardi M, Kirova Y, Fergusson P, Northend M, Hawkes E, Lee D, Doo NW, Barraclough A, Opat S, Cheah CY, Salvaris R, Ku M, Hamad N, Mutsando H, Tedjaseputra A, Gilbertson M, Marconi T, Viiala N, Palese M, Shankar A, Maurer MJ, Natkunam Y, Kelly KM, Borchmann P, Hoppe RT, Binkley MS. Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses. Blood Adv. 2026 Aug 11; 10(15):5338-5347.
-
Budde LE, Kamdar M, Assouline SE, Chavez JC, Ghosh N, Ollila TA, Hodson DJ, Modi D, Bastos-Oreiro M, Naik SG, Nakhoda SK, Lee Batlevi C, Wang J, Makadia S, Kwan A, Penuel E, Jing J, Wu H, Ead W, Pham S, To I, Wei MC, Wang ML. Mosunetuzumab plus polatuzumab vedotin for relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study. Blood. 2026 Aug 06; 148(6):682-692.
-
Clarke JE, Yu A, Kawakibi T, Le M, Pack D, Alves C, Acharya J. Diagnostic and Imaging Features of Leber Hereditary Optic Neuropathy: An Individual Participant Data Meta-Analysis. AJNR Am J Neuroradiol. 2026 Aug 03; 47(8):2227-2235.
-
Nash SH, Loeffler BT, Erdrich J, Verhage E, Sorensen J, Slater VE, Elenwa F, Ivanich JD, Smith BJ, Ulmer KK, McDowell BD. Impact of Comorbidities on Survival among American Indian and Alaska Native People with Cancer: A Surveillance, Epidemiology, and End Results-Medicare Study. Cancer Epidemiol Biomarkers Prev. 2026 Aug 03; 35(8):1317-1328.
-
Lewis CJ, Shirvan L, Johnston JM, Groden C, Yang J, Ashton A, Chong J, Moran M, Akmal H, Chipman SI, Zampieri C, Wickstrom J, Matsubara J, Lehky T, Alter KE, Toro C, Tifft CJ. Similarities and differences in the late-onset GM2 gangliosidoses: Tay-Sachs and Sandhoff diseases. J Neurol. 2026 Aug 03; 273(8).
-
Mullens CL, Diaz A, Bredbeck BC, Kunnath N, Dimick JB, Ibrahim AM. Rural Residence and Postsurgical Outcomes Among Medicare Beneficiaries. JAMA Netw Open. 2026 Aug 03; 9(8):e2626959.
-
Huang Y, Santoni G, Petrick JL, Wocalewski V, Sparrelid E, Xie SH. Menopausal hormone therapy and risk of liver cancer in a Swedish population-based cohort study. J Natl Cancer Inst. 2026 Aug 01; 118(8):1478-1484.
-
April MD, Butler H, Demasi SC, Aggarwal NR, Andrea LJ, Barker AB, Barnes CR, Brainard JC, Brewer JM, Driver BE, Gaillard JP, Gandotra S, Ghamande SA, Gibbs KW, Herbert JT, Hughes CG, Janz DR, Joffe AM, Khan A, Kramer PJ, Latimer AJ, Mitchell SH, Moskowitz AL, Page DB, Prekker ME, Resnick-Ault D, Self WH, Smith LM, Sottile PD, Stempek SB, Trent SA, Vonderhaar DJ, Walker JE, White HD, Semler MW, Casey JD, Schauer SG, Ginde AA. Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials. Am J Respir Crit Care Med. 2026 Aug 01; 212(8):1740-1749.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|